.Pfizer and Valneva may have concerning two even more years to stand by before they create the very ...
.Let's dive into a talk with Ayla Ellison, Strong Biotech Managing Editor and also Michelle Benz as ...
.Bayer put on hold the phase 3 trial for its own element XIa inhibitor asundexian behind time in 201...
.Sanofi is still bented on taking its a number of sclerosis (MS) med tolebrutinib to the FDA, execs ...
.Galapagos is actually coming under added stress from financiers. Having built a 9.9% stake in Galap...
.Invite to today's Chutes & Ladders, our roundup of notable management hirings, firings as well a...
.Shanghai Allist Pharmaceuticals has actually bought itself a starring job in China's KRAS market, s...
.ReNeuron has joined the long listing of biotechs to leave behind Greater london's AIM stock exchang...
.MBX Biosciences has contributed to the latest spurt of IPO filings. The biotech, which submitted it...
.For Lykos Therapeutics and the company's prospective MDMA-assisted therapy for trauma (PTSD), the f...